Journals / Acta Medica Nicomedia / 2020 / Cilt: 3 - Sayı: 3

RELATIONSHIPS OF BODY MASS INDEX WITH PROGNOSTIC FACTORS AND SURVIVAL IN ENDOMETRIAL CANCER

Endometrium Kanserinde Vücut Kitle İndeksinin Prognostik Faktörler ve Sağkalım ile İlişkisi

Pages
94–99
Publication Date
2020-10-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The BMI, age of diagnosis, menopausal status, tumor size, histopathological type of tumor, tumor grade, myometrial invasion, cervical invasion, lymph node involvement, radiotherapy (RT) status, RT type, chemotherapy (KT) regimens, recurrence and metastasis status, disease-free survival and overall survival of the patients were determined retrospectively.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of the study is to investigate the effect of body mass index (BMI) on prognostic factors and survival in patients with endometrial cancer.
📊
Key Findings & Data:Methods: A total of 247 patients with endometrial cancer were evaluated.
💡
Conclusion & Impact:The BMI, age of diagnosis, menopausal status, tumor size, histopathological type of tumor, tumor grade, myometrial invasion, cervical invasion, lymph node involvement, radiotherapy (RT) status, RT type, chemotherapy (KT) regimens, recurrence and metastasis status, disease-free survival and overall survival of the patients were determined retrospectively.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:vücut kitle indeksi · endometrium kanseri · prognoz

Abstract

Objective: The aim of the study is to investigate the effect of body mass index (BMI) on prognostic factors and survival in patients with endometrial cancer. Methods: A total of 247 patients with endometrial cancer were evaluated. The BMI, age of diagnosis, menopausal status, tumor size, histopathological type of tumor, tumor grade, myometrial invasion, cervical invasion, lymph node involvement, radiotherapy (RT) status, RT type, chemotherapy (KT) regimens, recurrence and metastasis status, disease-free survival and overall survival of the patients were determined retrospectively. The relationship between BMI and prognostic factors is evaluated with chi-square test and survival analysis is evaluated using Kaplan-meier and cox analysis. The BMI of the patients were categorized into 3 groups as

Özet

Amaç: Endometriyum kanseri tanısı almış hastalarda vücut kitle indeksinin prognostik faktörler ve sağkalıma etkisinin araştırılmasıdır. Yöntem: Bu çalışma tek merkezli retrospektif klinik çalışmadır. Endometriyum kanseri tanısı almış 247 hasta değerlendirilmiştir. Hastaların VKİ’si, tanı yaşı, menapoz durumları, tümör çapı, tümörün histopatolojik tipi, gradı, evresi, myometriyal invazyon, servikal invazyon, lenf nodu tutulumu, RT durumu, RT tipi, aldığı KT rejimleri, nüks ve metastaz durumları, hastalıksız sağkalım ve genel sağkalımları belirlendi. VKİ’nin prognostik faktörlerle ilişkisi ki-kare testi, sağkalım analizi ise Kaplan-meier ve cox analizi kullanılarak değerlendirilmiştir. Bulgular: Hastaların VKİ’i

🔖

Cite This Article

YENİHAYAT, E. M., KEFELİ, U., ÇABUK, D., IŞIK, U., ÖZDEN, E., ÇAKMAK, Y., UYGUN, K. (2020). RELATIONSHIPS OF BODY MASS INDEX WITH PROGNOSTIC FACTORS AND SURVIVAL IN ENDOMETRIAL CANCER. Acta Medica Nicomedia, Cilt: 3 - Sayı: 3, 94–99. https://ajindex.com/articles/450012

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87
  2. Siegel R, Naishadham D,Jemal A. Canser statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29
  3. Ali AT. Risk factors for endometrial cancer. Ceska Gynekol. 2013;78(5):448-459
  4. Reeves KW, Carter GC, Rodabough RJ, et al. Obesity in relation to endometrial cancer risk and disease characteristics in the Women’s Health Initiative. Gynecol Oncol. 2011;121(2):376–382
  5. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA.2016;315(21):2284-2291
  6. World Cancer Research Fund/American Institute for Cancer Research: Continuous Update Project Report. Food: Nutrition, Physical Activity, and the Prevention of Endometrial Cancer. 2013
  7. McCullough ML, Patel AV, Patel R, et al. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomarkers Prev. 2008;17(1):73-79
  8. Smits A, Lopez A, Das N, Bekkers R, Galaal K. The impacts of BMI on quality of life in obese endometrial cancer survivors: Does size matter? Gynecol Oncol. 2014;132(1):137-141
  9. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15(1):10-17
  10. National Cancer Institute. SEER stat fact sheets: endometrial cancer. Surveillance, Epidemiology, and End Results (SEER) Program. Available at http://seer.cancer.gov/statfacts/html/corp.html. Accessed: May 06, 2019
  11. Lee NK, Cheung MK, Shin JY,Husain A, Teng NN, Berek JS, et al. Prognostic factors for uterine cancer in reproductive-aged women. Obstet Gynecol. 2007;109(3):655–662
  12. Lurain JR, Rice BL, Rademaker AW, Poggensee LE, Schink JC, Miller DS. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol. 1991;78(1):63–69
  13. Bourgin C, Saidani M, Poupon C, et al. Endometrial cancer in elderly women: which disease, which surgical management? A systematic review of the literature. EJSO - European Journal of Surgical Oncology.2016;42(2):166-175
  14. Keys HM, Roberts JA, Brunetto VLet al. A Phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92(3):744–751
  15. Nevadunsky NS, van Arsdale A, Strickler HD, et al. Obesity and age at diagnosis of endometrial cancer. Obstet Gynecol. 2014;124(2):300-